This week on Tech Byte we travel to the Vascular Institute of Chattanooga for Dr. Will Harris to show us a new tech they have to help treat Peripheral Arterial Disease (PAD) that is new to this end of ...

According to the National Heart, Lung, and Blood Institute, nearly 10 million people aged 40 and older have Peripheral Artery ...

Here are some common myths about heart disease in women. Debunking these is important to raise awareness and promote heart ...

A post-hoc analysis of STRIDE confirms the benefit of GLP-1 RA in patients with peripheral arterial disease and type 2 ...

A “slow developing” symptom in the feet could be a warning sign of high cholesterol and even heart disease. This lesser-known sign could indicate that fatty deposits have built up in your arteries.

Peripheral artery disease (PAD) is a chronic and progressive condition characterised by narrowing or blockage of peripheral arteries, primarily affecting the lower limbs. 1 More than 200 million ...

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and limb events and mortality, researchers reported at the Society for ...

A new statement from leading heart and blood vessel experts in Europe is providing clinical guidance for treatments to ...

CIDP is an autoimmune disease in which the immune system's B-cells attack the peripheral nervous system. In the current study, the CAR CD19 T-cell therapy was used to combat these rogue B-cells.

Peripheral Artery Disease (PAD) is a common yet often underrecognized vascular condition affecting over 8.5 million Americans, with incidence sharply increasing among those over 65. In Southeast ...